Application Sponsors
ANDA 211860 | BAXTER HLTHCARE CORP | |
Marketing Status
Application Products
001 | POWDER;INTRAVENOUS | EQ 150MG BASE/VIAL | 0 | FOSAPREPITANT DIMEGLUMINE | FOSAPREPITANT DIMEGLUMINE |
FDA Submissions
UNKNOWN; | ORIG | 1 | AP | 2019-09-05 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
BAXTER HLTHCARE CORP
cder:Array
(
[0] => Array
(
[ApplNo] => 211860
[companyName] => BAXTER HLTHCARE CORP
[docInserts] => ["",""]
[products] => [{"drugName":"FOSAPREPITANT DIMEGLUMINE","activeIngredients":"FOSAPREPITANT DIMEGLUMINE","strength":"EQ 150MG BASE\/VIAL","dosageForm":"POWDER;INTRAVENOUS","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"09\/05\/2019","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
[supplements] =>
[actionDate] => 2019-09-05
)
)